GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (BOM:540596) » Definitions » Cyclically Adjusted PB Ratio

Eris Lifesciences (BOM:540596) Cyclically Adjusted PB Ratio : 10.31 (As of May. 22, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Cyclically Adjusted PB Ratio?

As of today (2024-05-22), Eris Lifesciences's current share price is ₹907.60. Eris Lifesciences's Cyclically Adjusted Book per Share for the fiscal year that ended in Mar23 was ₹88.04. Eris Lifesciences's Cyclically Adjusted PB Ratio for today is 10.31.

The historical rank and industry rank for Eris Lifesciences's Cyclically Adjusted PB Ratio or its related term are showing as below:

BOM:540596' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 6.5   Med: 8.25   Max: 10.39
Current: 10.07

During the past 11 years, Eris Lifesciences's highest Cyclically Adjusted PB Ratio was 10.39. The lowest was 6.50. And the median was 8.25.

BOM:540596's Cyclically Adjusted PB Ratio is ranked worse than
93.03% of 674 companies
in the Drug Manufacturers industry
Industry Median: 1.855 vs BOM:540596: 10.07

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Eris Lifesciences's adjusted book value per share data of for the fiscal year that ended in Mar23 was ₹161.479. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹88.04 for the trailing ten years ended in Mar23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eris Lifesciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Eris Lifesciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Cyclically Adjusted PB Ratio Chart

Eris Lifesciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 9.96 6.50

Eris Lifesciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 6.50 - - -

Competitive Comparison of Eris Lifesciences's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Eris Lifesciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eris Lifesciences's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eris Lifesciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Eris Lifesciences's Cyclically Adjusted PB Ratio falls into.



Eris Lifesciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Eris Lifesciences's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=907.60/88.04
=10.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eris Lifesciences's Cyclically Adjusted Book per Share for the fiscal year that ended in Mar23 is calculated as:

For example, Eris Lifesciences's adjusted Book Value per Share data for the fiscal year that ended in Mar23 was:

Adj_Book=Book Value per Share/CPI of Mar23 (Change)*Current CPI (Mar23)
=161.479/146.8646*146.8646
=161.479

Current CPI (Mar23) = 146.8646.

Eris Lifesciences Annual Data

Book Value per Share CPI Adj_Book
201403 12.837 91.425 20.621
201503 19.321 97.163 29.204
201603 23.334 102.518 33.428
201703 41.246 105.196 57.584
201803 62.641 109.786 83.797
201903 83.662 118.202 103.949
202003 95.472 124.705 112.437
202103 116.100 131.771 129.399
202203 140.389 138.822 148.523
202303 161.479 146.865 161.479

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eris Lifesciences  (BOM:540596) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Eris Lifesciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eris Lifesciences (BOM:540596) Business Description

Traded in Other Exchanges
Address
Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (BOM:540596) Headlines

No Headlines